News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,548 Results
Type
Article (7573)
Company Profile (40)
Press Release (175921)
Multimedia
Podcasts (26)
Webinars (4)
Section
Business (49081)
Career Advice (493)
Deals (9660)
Drug Delivery (24)
Drug Development (34395)
Employer Resources (20)
FDA (4517)
Job Trends (3785)
News (93844)
Policy (6597)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (526)
Academic (1)
Accelerated approval (28)
Adcomms (12)
Allergies (80)
Alliances (8310)
ALS (99)
Alzheimer's disease (777)
Antibody-drug conjugate (ADC) (210)
Approvals (4878)
Artificial intelligence (167)
Autoimmune disease (143)
Automation (13)
Bankruptcy (65)
Best Places to Work (3507)
BIOSECURE Act (7)
Biosimilars (82)
Biotechnology (31)
Bladder cancer (110)
Brain cancer (24)
Breast cancer (388)
Cancer (2977)
Cardiovascular disease (235)
Career advice (396)
Career pathing (9)
CAR-T (115)
CDC (11)
Celiac Disease (2)
Cell therapy (357)
Cervical cancer (16)
Clinical research (32371)
Collaboration (594)
Company closure (1)
Compensation (188)
Complete response letters (28)
COVID-19 (823)
CRISPR (38)
C-suite (250)
Cystic fibrosis (72)
Data (4728)
Denatured (1)
Depression (81)
Dermatology (59)
Diabetes (332)
Diagnostics (1783)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (98)
Drug pricing (32)
Drug shortages (2)
Duchenne muscular dystrophy (102)
Earnings (35717)
Editorial (21)
Employer branding (1)
Employer resources (21)
Events (31688)
Executive appointments (242)
FDA (6434)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (14)
Funding (581)
Gene editing (88)
Generative AI (9)
Gene therapy (311)
GLP-1 (517)
Government (946)
Grass and pollen (4)
Guidances (316)
Healthcare (4833)
HIV (40)
Huntington's disease (24)
IgA nephropathy (83)
Immunology and inflammation (125)
Immuno-oncology (50)
Indications (111)
Infectious disease (979)
Inflammatory bowel disease (108)
Inflation Reduction Act (2)
Influenza (78)
Intellectual property (102)
Interviews (92)
IPO (5970)
IRA (7)
Job creations (506)
Job search strategy (329)
JPM (23)
Kidney cancer (14)
Labor market (25)
Layoffs (100)
Leadership (11)
Legal (884)
Liver cancer (42)
Longevity (6)
Lung cancer (449)
Lymphoma (258)
Machine learning (18)
Management (6)
Manufacturing (240)
MASH (107)
Medical device (2986)
Medtech (3017)
Mergers & acquisitions (4195)
Metabolic disorders (758)
mRNA (65)
Multiple sclerosis (80)
NASH (7)
Neurodegenerative disease (186)
Neuropsychiatric disorders (47)
Neuroscience (1472)
NextGen: Class of 2026 (1266)
Non-profit (655)
Now hiring (5)
Obesity (314)
Opinion (61)
Ovarian cancer (108)
Pain (126)
Pancreatic cancer (159)
Parkinson's disease (182)
Partnered (9)
Patents (171)
Patient recruitment (312)
Peanut (26)
People (8608)
Pharmaceutical (8)
Pharmacy benefit managers (5)
Phase 1 (9474)
Phase 2 (15910)
Phase 3 (10469)
Pipeline (5161)
Policy (64)
Postmarket research (889)
Preclinical (3066)
Press Release (7)
Prostate cancer (158)
Psychedelics (21)
Radiopharmaceuticals (117)
Rare diseases (503)
Real estate (583)
Recruiting (11)
Regulatory (7061)
Reports (22)
Research institute (523)
Resumes & cover letters (97)
Rett syndrome (21)
RNA editing (6)
RSV (43)
Schizophrenia (101)
Series A (149)
Series B (64)
Service/supplier (1)
Sickle cell disease (57)
Special edition (10)
Spinal muscular atrophy (54)
Sponsored (16)
Startups (719)
State (1)
Stomach cancer (6)
Supply chain (21)
Tariffs (20)
The Weekly (25)
Vaccines (363)
Venture capital (31)
Weight loss (183)
Women's health (37)
Worklife (6)
Date
Today (80)
Last 7 days (287)
Last 30 days (1637)
Last 365 days (12999)
2026 (5587)
2025 (12983)
2024 (13513)
2023 (14784)
2022 (17492)
2021 (17688)
2020 (15675)
2019 (11146)
2018 (8294)
2017 (8639)
2016 (7271)
2015 (8840)
2014 (5989)
2013 (4071)
2012 (4255)
2011 (4684)
2010 (4184)
Location
Africa (173)
Alabama (19)
Alaska (1)
Arizona (58)
Arkansas (4)
Asia (11436)
Australia (1921)
California (5769)
Canada (1563)
China (601)
Colorado (202)
Connecticut (309)
Delaware (200)
Europe (27737)
Florida (778)
Georgia (180)
Hawaii (2)
Idaho (13)
Illinois (369)
India (38)
Indiana (236)
Iowa (5)
Japan (258)
Kansas (51)
Kentucky (19)
Louisiana (14)
Maine (29)
Maryland (588)
Massachusetts (4003)
Michigan (98)
Minnesota (231)
Mississippi (3)
Missouri (45)
Montana (5)
Nebraska (2)
Nevada (55)
New Hampshire (13)
New Jersey (1692)
New Mexico (3)
New York (1521)
North Carolina (484)
North Dakota (2)
Northern California (2979)
Ohio (103)
Oklahoma (1)
Oregon (9)
Pennsylvania (1139)
Puerto Rico (4)
Rhode Island (6)
South America (291)
South Carolina (5)
Southern California (2295)
Tennessee (54)
Texas (906)
United States (19258)
Utah (115)
Vermont (1)
Virginia (114)
Washington D.C. (26)
Washington State (400)
Wisconsin (31)
183,548 Results for "a2 biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A2 Biotherapeutics Presents Safety and Efficacy Data from the EVEREST-2 Clinical Study, Including Update on the First Complete Response to CAR T-Cell Therapy in a Patient with Non-Small Cell Lung Cancer
May 22, 2026
·
6 min read
Press Releases
A2 Biotherapeutics Receives U.S. FDA Fast Track Designation for A2B543, a Logic-Gated CAR T-Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster
April 2, 2026
·
2 min read
Press Releases
A2 Biotherapeutics Doses First Patient in EVEREST-2 Study with A2B543, a Logic-Gated CAR T Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster
February 26, 2026
·
5 min read
Press Releases
A2 Biotherapeutics to Highlight Progress of CAR T-Cell Clinical Programs in Three Poster Presentations During the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
April 23, 2026
·
3 min read
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Press Releases
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
• Strong global consensus on measurement and role of ammonia in Hepatic Encephalopathy (HE) • Phase 2a results of YAQ007 (oral OPA) show ammonia reduction • Utility of rifaximin in HE defined more narrowly
April 20, 2026
·
1 min read
Press Releases
Iovance Biotherapeutics to Present at Upcoming Conference
May 21, 2026
·
3 min read
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
Candid Therapeutics follows closely behind Neurona Therapeutics, which UCB acquired in mid-April in a potential $1.15 billion deal.
May 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
A2 Biotherapeutics Presents Initial Safety and Efficacy Data from Ongoing Phase 1/2 EVEREST-2 Study, Including First Report of a Complete Response to CAR T-Cell Therapy in a Patient with NSCLC
November 10, 2025
·
8 min read
Press Releases
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 17, 2026
·
8 min read
1 of 18,355
Next
